AnaptysBio, Inc.ANABNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank0
3Y CAGR-69.9%
5Y CAGR-50.3%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
-69.9%/yr
vs +12.1%/yr prior
5Y CAGR
-50.3%/yr
Recent deceleration
Acceleration
-82.0pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$2.42M-98.5%
2024$163.84M+23.9%
2023$132.28M+49.0%
2022$88.80M-9.8%
2021$98.50M+23.1%
2020$80.03M-19.4%
2019$99.34M+76.8%
2018$56.20M+90.9%
2017$29.44M+91.0%
2016$15.42M-